The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19

Pharmacol Res. 2020 Sep:159:105046. doi: 10.1016/j.phrs.2020.105046. Epub 2020 Jun 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / pharmacology
  • Betacoronavirus*
  • COVID-19
  • COVID-19 Drug Treatment
  • China / epidemiology
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / virology
  • Databases, Pharmaceutical*
  • Drug Evaluation, Preclinical / methods
  • Drugs, Chinese Herbal / pharmacology*
  • Host Microbial Interactions / drug effects
  • Humans
  • Medicine, Chinese Traditional
  • Pandemics
  • Phytotherapy*
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / virology
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Drugs, Chinese Herbal